Heterogeneity among septic shock patients in a set of immunoregulatory markers

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 33, Issue 3, 2014, Pages 313-324

  Janols, H ^a   Wullt, M ^a   Bergenfelz, C ^a   Bjornsson S ^a   Lickei, H ^b   Janciauskiene, S ^b   Leandersson, K ^a   Bredberg, A ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD163 ANTIGEN; CD40 ANTIGEN; GLYCOPROTEIN P 15095; HLA DR ANTIGEN; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; LYMPHOCYTE SURFACE MARKER; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD CULTURE; CELL HETEROGENEITY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GRAM NEGATIVE SEPSIS; GRAM POSITIVE INFECTION; HUMAN; IMMUNE RESPONSE; IMMUNE STATUS; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE; MALE; MIDDLE AGED; MONOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY T LYMPHOCYTE; SEPTIC SHOCK; T LYMPHOCYTE ACTIVATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BACTEREMIA; BIOLOGICAL MARKERS; CYTOKINES; FEMALE; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; MONOCYTES; RECEPTORS, CELL SURFACE; SHOCK, SEPTIC; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84896708263     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-013-1957-y     Document Type: Article

References (41)

1. Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348(16):1546-1554
2. Harrison DA, Welch CA, Eddleston JM (2006) The epidemiology of severe sepsis in England, Wales and Northern Ireland, 1996 to 2004: secondary analysis of a high quality clinical database, the ICNARC Case Mix Programme Database. Crit Care 10(2):R42
3. Melamed A, Sorvillo FJ (2009) The burden of sepsis-associated mortality in the United States from 1999 to 2005: an analysis of multiple-cause-of-death data. Crit Care 13(1):R28
4. Wiersinga WJ (2011) Current insights in sepsis: from pathogenesis to new treatment targets. Curr Opin Crit Care 17(5):480-486
5. Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348(2):138-150
6. Ulloa L, Tracey KJ (2005) The "cytokine profile": a code for sepsis. Trends Mol Med 11(2):56-63
7. Hotchkiss RS, Opal S (2010) Immunotherapy for sepsis - a new approach against an ancient foe. N Engl J Med 363(1):87-89
8. Angus DC (2011) The search for effective therapy for sepsis: back to the drawing board? JAMA 306(23):2614-2615
9. Wenzel RP, Edmond MB (2012) Septic shock - evaluating another failed treatment. N Engl J Med 366(22):2122-2124
10. Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, Gao H et al (2011) A genomic storm in critically injured humans. J Exp Med 208(13):2581-2590
11. Ward PA (2011) Immunosuppression in sepsis. JAMA 306(23):2618-2619
12. Sinistro A, Almerighi C, Ciaprini C, Natoli S, Sussarello E, Di Fino S et al (2008) Downregulation of CD40 ligand response in monocytes from sepsis patients. Clin Vaccine Immunol 15(12):1851-1858
13. Skrupky LP, Kerby PW, Hotchkiss RS (2011) Advances in the management of sepsis and the understanding of key immunologic defects. Anesthesiology 115(6):1349-1362
14. Huttunen R, Aittoniemi J (2011) New concepts in the pathogenesis, diagnosis and treatment of bacteremia and sepsis. J Infect 63(6):407-419
15. Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM et al (1999) Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 27(7):1230-1251
16. Schwulst SJ, Grayson MH, DiPasco PJ, Davis CG, Brahmbhatt TS, Ferguson TA et al (2006) Agonistic monoclonal antibody against CD40 receptor decreases lymphocyte apoptosis and improves survival in sepsis. J Immunol 177(1):557-565
17. Unsinger J, Kazama H, McDonough JS, Hotchkiss RS, Ferguson TA (2009) Differential lymphopenia-induced homeostatic proliferation for CD4+ and CD8+ T cells following septic injury. J Leukoc Biol 85(3):382-390
18. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101(6):1644-1655
19. Wieczorek G, Asemissen A, Model F, Turbachova I, Floess S, Liebenberg V et al (2009) Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue. Cancer Res 69(2):599-608
20. Bourgeois C, Rocha B, Tanchot C (2002) A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory. Science 297(5589):2060-2063
21. Brunialti MK, Santos MC, Rigato O, Machado FR, Silva E, Salomao R (2012) Increased percentages of T helper cells producing IL-17 and monocytes expressing markers of alternative activation in patients with sepsis. PLoS One 7(5):e37393
22. Janols H, Bredberg A, Thuvesson I, Janciauskiene S, Grip O, Wullt M (2010) Lymphocyte and monocyte flow cytometry immunophenotyping as a diagnostic tool in uncharacteristic inflammatory disorders. BMC Infect Dis 10:205
23. Sica A, Mantovani A (2012) Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122(3):787-795
24. Moore CS, Crocker SJ (2012) An alternate perspective on the roles of TIMPs and MMPs in pathology. Am J Pathol 180(1):12-16
25. Barreiro LB, Tailleux L, Pai AA, Gicquel B, Marioni JC, Gilad Y (2012) Deciphering the genetic architecture of variation in the immune response to Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A 109(4):1204-1209
26. Lin RY, Astiz ME, Saxon JC, Rackow EC (1993) Altered leukocyte immunophenotypes in septic shock. Studies of HLA-DR, CD11b, CD14, and IL-2R expression. Chest 104(3):847-853
27. Xu PB, Lou JS, Ren Y, Miao CH, Deng XM (2012) Gene expression profiling reveals the defining features of monocytes from septic patients with compensatory anti-inflammatory response syndrome. J Infect 65(5):380-391
28. Brunialti MK, Martins PS, Barbosa de Carvalho H, Machado FR, Barbosa LM, Salomao R (2006) TLR2, TLR4, CD14, CD11B, and CD11C expressions on monocytes surface and cytokine production in patients with sepsis, severe sepsis, and septic shock. Shock 25(4):351-357
29. Biswas SK, Lopez-Collazo E (2009) Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 30(10):475-487, Research Support, Non-U.S. Gov't Review
30. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29(7):1303-1310
31. Opal SM, Girard TD, Ely EW (2005) The immunopathogenesis of sepsis in elderly patients. Clin Infect Dis 41(Suppl 7):S504-S512
32. Schröder J, Kahlke V, Staubach KH, Zabel P, Stüber F (1998) Gender differences in human sepsis. Arch Surg 133(11):1200-1205
33. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR et al (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405(6785):458-462
34. Serhan CN (2007) Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 25:101-137
35. Boomer JS, Shuherk-Shaffer J, Hotchkiss RS, Green JM (2012) A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis. Crit Care 16(3):R112
36. Porta C, Riboldi E, Totaro MG, Strauss L, Sica A, Mantovani A (2011) Macrophages in cancer and infectious diseases: the 'good' and the 'bad'. Immunotherapy 3(10):1185-1202
37. Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH et al (2011) Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 306(23):2594-2605
38. Amlot PL, Tahami F, Chinn D, Rawlings E (1996) Activation antigen expression on human T cells. I. Analysis by two-colour flow cytometry of umbilical cord blood, adult blood and lymphoid tissue. Clin Exp Immunol 105(1):176-182
39. Naka T, Nishimoto N, Kishimoto T (2002) The paradigm of IL-6: from basic science to medicine. Arthritis Res 4(Suppl 3):S233-S242
40. Brahmamdam P, Inoue S, Unsinger J, Chang KC, McDunn JE, Hotchkiss RS (2010) Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis. J Leukoc Biol 88(2):233-240
41. Meisel C, Schefold JC, Pschowski R, Baumann T, Hetzger K, Gregor J et al (2009) Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med 180(7):640-648